QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ibio-announces-new-preclinical-data-from-obese-nhp-study-evaluating-ibio-610-activin-e-antibody-candidate-supported-by-preclinical-data

Previously reported data showed that in a diet-induced obesity mouse model, IBIO-610 drives fat-selective, GLP-1-synergistic we...

 why-did-ibio-shares-surge-over-11-in-pre-market-trading

iBio shares rose sharply after announcing upcoming presentations on its obesity treatment candidate at two industry conferences.

 oppenheimer-initiates-coverage-on-ibio-with-outperform-rating-announces-price-target-of-5

Oppenheimer analyst Jay Olson initiates coverage on iBio (NASDAQ:IBIO) with a Outperform rating and announces Price Target o...

 leerink-partners-initiates-coverage-on-ibio-with-outperform-rating-announces-price-target-of-2

Leerink Partners analyst Roanna Ruiz initiates coverage on iBio (NASDAQ:IBIO) with a Outperform rating and announces Price T...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION